ATAI Life Sciences N.V.

ATAI Life Sciences N.V.

ATAI

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.49B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
ATAI Life Sciences N.V.ATAI Life Sciences N.V.-1.4--334%--
$12.33

Target Price by Analysts

200.8% upsideATAI Life Sciences N.V. Target Price DetailsTarget Price
$0.00

Current Fair Value

100% downside

Overvalued by 100% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.49 Billion
Enterprise Value$1.46 Billion
Dividend Yield$- (-)
Earnings per Share$-2.91
Beta1.61
Outstanding Shares226,532,786

Return

Return on Equity-333.90%ROE
Return on Assets-250.46%
Return on Invested Capital-52.39%

Valuation & Multiples

P/E Ratio-1.35P/E Ratio
PEG-10.67PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue417.18
Enterprise Value to EBIT-11.58
Enterprise Value to Net Income-3
Total Debt to Enterprise0
Debt to Equity0.02Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 13, 2026
EPS Estimate
$-0.11
Average shareholder expectation
Revenue Estimate
$125,000
Average shareholder expectation

Next Earnings Call

Expected Date
August 13, 2026
EPS Estimate
$-0.10
Average shareholder expectation
Revenue Estimate
$111,111
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.2430 3.87%
Total Calls1,122,400 12.26%
Total Puts272,700 33.55%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %44.01% 22.58%
Total Invested$357.55M 80.10%
Investors Holding192 67.00%

ESG Score

No data

About ATAI Life Sciences N.V.

35 employees